London: Scientists have identified a novel potential biomarker, present in cerebral spinal fluid (CSF), that can help detect Alzheimer`s disease at least a decade before symptoms appear. This may be the earliest known biomarker associated with the risk of developing Alzheimer`s disease. "If our initial findings can be replicated by other laboratories, the results will change the way we currently think about the causes of Alzheimer`s disease," said Dr Ramon Trullas, research professor at the Spanish National Research Council (CSIC) Institute of Biomedical Research of Barcelona and lead author of the study. "This discovery may enable us to search for more effective treatments that can be administered during the preclinical stage," Trullas said.
Breastfeeding may ward off breast cancer in women
Early Alzheimer`s test could help prevent dementia